Background
Methods
Results
Report section | Item | Item # | % articles with STROBE criteria not met | ||
---|---|---|---|---|---|
Clinical burden | Economic burden | Humanistic burden | |||
Title and abstract
|
Title
| 1a | 20% | 40% | 10% |
Abstract
| 1b | 13% | 30% | 0% | |
Introduction
|
Background/rationale
| 2 | 0% | 0% | 0% |
Objective
| 3 | 0% | 0% | 0% | |
Methods
|
Study design
| 4 | 3% | 10% | 0% |
Setting
| 5 | 0% | 0% | 0% | |
Participants
| 6a | 13% | 10% | 0% | |
6b | 30% | 10% | 10% | ||
Variables
| 7 | 23% | 30% | 30% | |
Data sources/measurement
| 8 | 10% | 10% | 0% | |
Bias
| 9 | 53% | 40% | 40% | |
Study size
| 10 | 20% | 30% | 30% | |
Quantitative variables
| 11 | 13% | 20% | 20% | |
Statistical methods
| 12a | 30% | 30% | 10% | |
12b | 47% | 60% | 20% | ||
12c | 70% | 60% | 50% | ||
12d | 60% | 60% | 30% | ||
12e | 77% | 50% | 80% | ||
Results
|
Participants
| 13a | 40% | 50% | 30% |
13b | 63% | 60% | 30% | ||
13c | 73% | 80% | 50% | ||
Descriptive data
| 14a | 37% | 50% | 20% | |
14b | 77% | 80% | 60% | ||
14c | 27% | 20% | 20% | ||
Outcome data
| 15 | 3% | 10% | 0% | |
Main results
| 16a | 27% | 30% | 0% | |
16b | 63% | 70% | 20% | ||
16c | 40% | 70% | 30% | ||
Other analyses
| 17 | 37% | 20% | 60% | |
Discussion
|
Key results
| 18 | 0% | 0% | 0% |
Limitations
| 19 | 7% | 20% | 20% | |
Interpretation
| 20 | 3% | 10% | 0% | |
Generalizability
| 21 | 3% | 10% | 20% | |
Other
|
Funding
| 22 | 23% | 40% | 20% |
Type of bias | Humanistic burden (n=4) | |
---|---|---|
Low risk | Unclear risk | |
Selection | 2 | 2 |
Performance | 3 | 1 |
Attrition | 2 | 2 |
Detection | 3 | 1 |
Clinical burden studies
Overview
Reference/Study period | Data source | Study objective | Inclusion criteria | Asthma definition |
---|---|---|---|---|
Retrospective cohort studies
| ||||
Sadatsafavi et al. 2010 [10] 1996 - 2000 | Administrative healthcare data | Determine direct medical costs of asthma-related healthcare in British Columbia | 5 to 55 years |
Narrow: ICD-9 493.x Broad: visits for an asthma-related diagnosis; hospitalizations with asthma among the discharge diagnoses |
≥4 asthma prescriptions in 1 year | ||||
≥1 asthma hospitalization | ||||
≥2 physician visits for asthma | ||||
Blais et al. 2011 [18] 1998 - 2005 | RAMQ database, | Determine relationship between better use of LTRA and asthma exacerbations in children | 5-15 years | Moderate or severe asthma exacerbations - an ED visit for asthma, a hospital admission for asthma, or a dispensed short-course (14 days) prescription of oral corticosteroids |
Diagnosed asthma | ||||
Initiating (mono)therapy with ICS or LTRA | ||||
Rosychuk et al. 2010 [19] Apr 1999 to Mar 2005 | Provincial administrative healthcare databases | Describe the epidemiology of asthma presentations to EDs for 3 main regions in the province of Alberta | All people registered under the AHCIP at any time in a given year | ICD-9 code 493.x or ICD-10 code J45.x as the first or second diagnosis fields in the ACCS |
Crighton et al. 2001 [20] Apr 1, 1988 to Mar 31, 2000 | DAD database at CIHI, | Examine the seasonal patterns and trends of asthma hospitalizations in relation to age and gender | NR | ICD-9-CM code 493 |
Ungar et al. 2011 [21] Nov 1, 2000 to Mar 31, 2003 | Interview data linked to administrative healthcare data. | Identify factors associated with asthma exacerbation causing ED visits or hospitalizations related to health status, socioeconomic status (SES), and drug insurance | 1 to 18 years | Physician-diagnosed asthma; ICD-9 493 or ICD-10 J45 |
Disano et al. 2010 [22] 2003 - 2006 | DAD database from CIHI, INSQP Deprivation Index, Statistics Canada Community Profiles | Examine inequalities between SES groups with respect to rates of ACSC-hospitalizations | Acute care cases of 0 to 75 years; asthma in children for age <20 years | NR |
Blais et al. 2009 [18] 2002 - 2004 | RAMQ database | Compare the use of healthcare services between new users of budesonide/formoterol and F/S | Asthma patients aged 16 to 65 years ≥1 claim for combination therapy in 2002 or 2003 and no claims for combination therapy for ≥1 year prior to first claim | ICD-9 codes 493.0, 493.1, 493.9 |
Rowe et al. 2009 [23] 1 Apr 1999–31 Mar 2005 | ACCS and other provincial databases. | Describe the epidemiology of asthma presentations to EDs made by adults in the province of Alberta, Canada | Asthmatic individuals aged 18 years | ICD-9 493.x or ICD-10 J45.x |
To et al. 2008 [24] 1994 - 1998 | DAD database from CIHI, OHIP records, RPDB database | Describe the prevalence of asthma; all-cause mortality; physician visits and hospitalizations for asthma and all causes; and seasonal and geographical variation of healthcare utilization in children | Children aged 0 to 9 years | At least 1 asthma hospitalization or 2 asthma OHIP claims within 3 years |
Lemiere et al. 2007 [25] 2001 - 2004 | RAMQ database, WRA patients | Compare clinical characteristics and use of medical resources between subjects with OA, WEA, and WRA | NR | Physician-diagnosed asthma OA, WEA, and WRA |
To et al. 2007 [26] 1994 to 2006 | HMDB database from CIHI, OHIP records, RPDB database; | Examine and predict the persistence of childhood asthma | Children born in 1994 diagnosed with asthma before their 6th birthday, followed up until their 12th birthday | 1 asthma hospitalization or 2 asthma physician claims within 3 years prior to age 6 years (ICD-9 493 or ICD-10 J45). Persistent asthma - additional claims during follow-up Remission asthma - no additional claims |
Agha et al. 2007 [27] 1993 - 2001 | DAD database at CIHI, SES from the 1996 Census data | Examine socioeconomic disparities in ACS and non-ACS admissions among birth cohorts in a universal health insurance setting | Children born alive in Toronto during 1993–2001 | The most responsible diagnosis in the CIHI DAD DB |
Gershon et al. 2007 [2] 1994/95 to 2001/202 | DAD from CIHI, OHIP | Understand the burden of asthma | Asthma patients from ON, aged 0–39 years | 1 DAD hospitalization record or 2 OHIP claims for asthma in a 3-year period |
Lougheed et al. 2006 [28] 2001 - 2002 | CIHI | Assess regional differences in ED visit rates and hospitalizations for asthma | ED visits for asthma | ICD-10 code J45.x |
Dik et al. 2006 [29] 1985 - 1998 | Manitoba administrative healthcare data | Study 14-year trends in utilization of physician resources for asthma and compare them to trends for allergic rhinitis | NR | ICD-9-CM code 493 |
Sin et al. 2001 [30] FY 1992 - 1996 | CIHI, drug claims, physician billing, and mortality databases | Determine the impact of ICS on rehospitalization for asthma and all-cause mortality rates in elderly patients | Asthmatic patients, aged ≥65 years, who had been hospitalized with a most responsible diagnosis of asthma in the past 5 years | ICD-9 codes 493.0, 493.1, and 493.9 |
Prospective cohort studies
| ||||
Rowe et al. 2010 [31] 2004 – 2005 | Interviews | Describe factors associated with admission to hospital for acute asthma after ED treatment | Patients aged 18 to 55 years diagnosed with asthma | Patient-reported |
Sin et al. 2003 [32] 1985, 1988 | AHCIP data, | Determine the relationship between SES and ED visits for asthma in a free access healthcare system. | Children born 1985 to 1988 followed for 10 years | ICD-9 code 493.x |
Ungar et al. 2001 [33] May - Oct 1995 | Telephone interviews at 1, 3, and 6 months, | Assess the cost of asthma care at the patient level in children from the perspectives of society, the Ontario Ministry of Health, and the patient. | Patients or caregivers filling prescriptions for bronchial inhalers | Probable asthma - a prescription for a bronchial inhaler medication in the last month (bronchodilator or corticosteroid) and reported experiencing shortness of breath, wheeze, or recurrent cough in the past |
Anis et al. 2000 [34] Sept 1, 1994 - Aug 31 1995 | Hospital ED, telephone interview for follow-up | Estimate the average direct cost of illness for 4 cardiorespiratory conditions | ED visitors who completed follow-up interviews | ED visit records |
Rowe et al. 2007 [23] 1996-1998 | Structured ED interview and telephone follow-up 2 weeks later | Compare ED asthma management and outcomesbetween Canada and US | Patients aged 2 to 54 years who presented with acute asthma in ED | NR |
Cross-sectional studies
| ||||
Boulet et al. 2008 [35] April - August 2004, | Telephone survey | Assess the influence of current and former smoking on self-reported asthma control and healthcare use | Adults aged 18 to 54 years with physician-diagnosed asthma for ≥6 months | Patient-reported or physician-diagnosed asthma |
Klomp et al. 2008 [36] 2002/03 and 2003/04 | Health databases in Saskatchewan | Describe the quality of asthma care using a set of proposed quality indicators | Saskatchewan residents who had a valid health insurance number | Over 1-year period: ≥3 prescriptions for antiasthma drug or ≥2 physician claims (ICD-9 code 493) or ≥2 hospitalization claims (ICD-9 493.x or ICD-10 J45.x) or ≥1 claim for physician services or hospitalization for asthma plus ≥1 pharmacy claim for an antiasthma drug |
Iron et al. 2003 [37] 1994/1995 | CNPHS data, OHIP | Determine the association between demographics, access to care, SES, and need (comorbidities) with actual family physician costs | Survey respondents aged ≥25 years consenting to share HC# and responses with MOHLTC | Self-reported |
Anis et al. 2001 [38] 1995 | Ministry of Health administrative databases | Determine whether excessive use of SABA, in conjunction with underuse of ICS, would be a marker for poorly controlled asthma and excessive use of healthcare resources | Asthma patients aged 5 to 50 years for whom ≥1 prescription for a SABA was filled in 1995 | Patients filling SABA prescriptions; for hospitalizations, ICD-9 code 08 (diseases of the respiratory system) |
Baibergenova et al. 2005 [39] April 1, 2001 to March 31, 2004 | Examine the pattern and strength of seasonal fluctuations in ED visits due to asthma | Asthma patients with ED visits for asthma or status asthmaticus | ICD-9 code 493.x or ICD-10 J45.0–J45.9 | |
Lynd et al. 2004 [40] NR | Survey | Assess the association between SES and SABA use, controlling for asthma severity | Asthmatic patients aged 19 to 50 years residing in the Greater Vancouver Regional District of British Columbia | NR |
Case–control study
| ||||
Suissa et al. 2002 [41] 1975 - 1997 | Saskatchewan Health DB | Assess whether regular use of ICS prevents asthma hospitalizations |
Source cohort: subjects aged 5–44 years receiving ≥3 prescriptions of an antiasthma medication in any 1-year period Full cohort: all subjects with ≥1 year follow-up, irrespective of whether they were admitted to hospital for asthma during the baseline year | Primary discharge diagnosis of asthma (ICD-9 codes 493.0, 493.1, or 493.9) |
Health economic analysis
| ||||
Seung et al. 2005 [42] 2004 | NACRS at CIHI, OCCI, MOHLTC billing | Determine the use of urgent care resources and annual costs for the uncontrolled asthmatic population in Canada | NR | ICD-9 Code 493 |
Key findings on clinical burden
Hospitalizations
Study | Number of patients | Patient descriptor | Year | Hospitalizations for asthma | |
---|---|---|---|---|---|
Per patient per year | Per 1000 patients per year | ||||
Children
| |||||
Blais et al. 2011 [43] | 7,494 | ≥1 exacerbations in the year prior to treatment initiation, ICS | 1998-2005 | 0.03 | |
≥1 exacerbations in the year prior to treatment initiation, LTRA | 0.06 | ||||
19,861 | No exacerbation in the year prior to treatment initiation: ICS | 0.005 | |||
No exacerbation in the year prior to treatment initiation: LTRA | 0.003 | ||||
Ungar et al. 2011 [21] | 490 | Asthmatic children | 2000-2003 | 0.25§ | |
To et al. 2008 [24] | 56,737 | 0-2 years | 1998/1999 | 86.7 | |
99,163 | 3-5 years | 27.3 | |||
141,305 | 6-9 years | 10.9 | |||
297,205 | Overall | 30.9 | |||
To et al. 2007 [26] | 34,216 | Persistent asthma | 1994-2006 | 63* | |
Remission asthma | 39* | ||||
Overall | 52* | ||||
Ungar et al. 2001 [33] | 339 | Asthma children | 1995 | 1 | |
Adults
| |||||
Sadatsafavi et al. 2010 [10] | 158,516 | Narrow asthma definition€ | 1996-2000 | 0.016 | |
Broad asthma definition¥ | 0.03 | ||||
Lemiere et al. 2007 [25] | 351 (WEA: 145, OA: 206) | WRA | 2001-2003 | 0.04(0.2) | |
NWRA | 0.008(0.7) | ||||
Anis et al. 2001 [38] | 4,671 | Appropriate use† | 1995 | 0.07(0.34) | |
763 | Inappropriate use‡ | 0.11(0.42) | |||
All ages
| |||||
Disano et al. 2010 [22] | NR | High SES | 2003-2006 | 1.61** | |
Average SES | 1.95** | ||||
Low SES | 2.7** | ||||
Klomp et al. 2008 [36] | 24,616 (24,180 of whom were still alive and living in the region the following year) | Asthma patients | 2002/2003 and 2003/2004 | 10.9 | |
Lougheed et al. 2006 [28] | 574,304 children and 1,194,095 adults in Ontario | Patients with an ED disposition diagnosis of asthma in a stratified sample of 16 hospitals | 2001-2002 | 108 (10.8%) children; 69 (6.9%) adults | |
Suissa et al. 2002 [41] | 30,569 | Source cohort†† | 1975-1997 | 48 | |
4,673 | Full cohort‡‡ | 42.4 | |||
Seung et al. 2005 [42] | NR | Asthma patients | 2004 | 1.43** |
ED visits
Reference | Number of patients | Descriptor | Annual mean number (SD) of ED visits per patient for asthma (range) | |
---|---|---|---|---|
From | To | |||
Children
| ||||
Blais et al. 2011 [43] | 27,355 | Children, 5–15 years, on ICS or LTRA therapy, by # of exacerbations in the previous year, 1998-2005 | 0.04* (on LTRA, no exacerb. in the previous year) | 0.32* (on ICS, 1+ exacerb. in the previous year) |
Lougheed et al. 2006 [28] | 4,674 | Ontario patients, <20 years, 2001-2002 | 13.6 [8.7 to 25.2]** | |
Sin et al. 2003 [32] | 90,845 | Children, 0–10 years, 1985–1988, by SES | 6 [0 to 31]** (very poor) | 7 [0 to 34]** (non-poor) |
Ungar et al. 2001 [33] | 339 | Children with asthma, <15 years, Ontario, 1995 | 0.8* | |
Adults
| ||||
Sin et al. 2001 [44] | elderly asthmatic, by ICS therapy | 1 (1.2)* (not using ICS) | 1.5 (1.3)* (using ICS) | |
Rowe et al. 2009 [45] | 48,942 | Adults, 1999/2000 to 2004/2005 | 6.7** (2004/2005) | 9.7** (1999/2000) |
Lemiere et al. 2007 [25] | 351 | Adults, work-related asthma, 2001-2004 | 0.2 (0.7)* (NWRA) | 0.3 (0.8)* (WRA) |
Lougheed et al. 2006 [28] | 3,993 | Adults, ≥20 years, 2001-2002 | 3.9 [1.7 to 10.1]** | |
Anis et al. 2001 [38] | 5,434 | Adults, use of SABA+ICS, 1995 | 0.04 (0.26)* (appropriate use∫) | 0.08 (0.33)* (inappropriate use∫) |
Rowe et al. 2007 [23] | 3,031 | Canada and US ED visits, 1996-1998 | 0(0–3)§ (US) | 1(0–3)§ (Canada) |
Baibergenova et al. 2005 [39] | 73,566 | Adult, Ontario, 2001-2004 | 0.45†
| |
All ages
| ||||
Rosychuk et al. 2010 [19] | 21,700 | Asthma patients, Alberta, 2004-2005 | 6.9(6.6-7.0)*** (Calgary) | 15.1(15.1-15.9)*** (NMU) |
Physician visits
Study | Number of patients | Patient descriptor | Year | Physician visits for asthma§
|
---|---|---|---|---|
Children
| ||||
To et al. 2008 [24] | 56,737 | 0-2 years | 1998/1999 | 2.2 |
99,163 | 3-5 years | 1.1 | ||
141,305 | 6-9 years | 0.8 | ||
297,205 | Overall | 1.2 | ||
Ungar et al. 2001 [33] | 339 | GP | 1995 | 3.6 |
Respiratory specialist | 2.1 | |||
Adults
| ||||
Boulet et al. 2008 [35] | 514 | Non-smoker | 2004 | 43% had ≥1 |
268 | Former smoker | 49% had ≥1 | ||
108 | Current smoker | 47% had ≥1 | ||
Lemiere et al. 2007 [25] | 351 (WEA: 145, OA: 206) | WRA | 2001-2003 | 4.1(4.3) |
NWRA | 1.2(1.7) | |||
Sadatsafavi et al. 2010 [10] | 158,516 | Narrow asthma definition | 1996-2000 | 1.86 |
Broad asthma definition | 3.85 | |||
Iron et al. 2003 [37] | 230* | Asthma patients | 1994/1995 | 4.3** |
Sin et al. 2001 [44] | 6,254 | No ICS (elderly) | 1992-1996 | 3.9(2.2) |
ICS (elderly) | 4(2.2) | |||
Anis et al. 2001 [38] | 4,671 | Appropriate use† | 1995 | 14.9(15.9) |
763 | Inappropriate use‡ | 16.7(19.3) | ||
Anis et al. 2000 [34] | 733 | Physician visits in ED | 1994-1995 | 1.0(1.3) |
Blais et al. 2009 [18] | 1264 | BUD/FORM | 2002-2004 | 7.5(7.4) |
1264 | FP/SM | 7.3(7) | ||
All ages
| ||||
Gershon et al. 2007 [2] | NR | All-cause claims | 1994/1995 | 13.2 |
1995/1996 | 12.5 | |||
1996/1997 | 12.0 | |||
1997/1998 | 12.1 | |||
1998/1999 | 11.9 | |||
1999/2000 | 11.6 | |||
2000/2001 | 11.5 | |||
2001/2002 | 11.2 |
Medication prescriptions
Economic burden studies
Overview
Reference/Study period | Data source | Study objective | Inclusion criteria | Asthma definition |
---|---|---|---|---|
Retrospective cohort studies
| ||||
Sadatsafavi et al. 2010 [10] 1996 - 2000 | Administrative healthcare data | Determine direct medical costs of asthma-related healthcare in British Columbia | Aged 5 to 55 years |
Narrow definition: ICD-9 code 493.x Broad definition: visits for an asthma-related diagnosis; hospitalizations with asthma among the discharge diagnoses |
≥4 asthma prescriptions in 1 year | ||||
≥1 asthma hospitalization | ||||
≥ 2 physician visits for asthma | ||||
Malo et al. 2008 [46] 1988 - 2002 | Administrative healthcare data, | Assess direct costs of CLI and CFI for OA and their association with selected variables | Subjects receiving compensation for OA | NR |
To et al. 2008 [24] 1994 - 1998 | DAD database from CIHI, OHIP records, RPDB database | Describe prevalence of asthma, all-cause mortality, physician visits, and hospitalizations for asthma and all causes; seasonal and geographical variation of healthcare utilization in children | Children aged 0–9 years | ≥1 asthma hospitalization or 2 asthma OHIP claims within 3 years |
Prospective cohort studies
| ||||
Ungar et al. 2001 [33] May - Oct 1995 | Telephone interviews at 1, 3, and 6 months | Assess cost of asthma care at the patient level in children from the perspectives of society, the Ontario Ministry of Health, and the patient | Patients or caregivers filling prescriptions for bronchial inhalers | Probable asthma - a prescription for a bronchial inhaler medication in the last month (bronchodilator or corticosteroid) and reported experiencing shortness of breath, wheeze, or recurrent cough in the past |
Anis et al. 2000 [34] Sept 1, 1994 - Aug 31 1995 | 2 hospital EDs in Saint John, NB; telephone interview for follow-up | Estimate average direct cost of illness for 4 cardiorespiratory conditions | ED visitors who completed follow-up interviews | ED visit records |
Cross-sectional studies
| ||||
Kohen et al. 2010 [47] Fall 1998 and Spring 1999 | NLSCY | Examine associations between asthma and school functioning | Individuals aged 7–15 years with complete data on the measures of interest | Past-year wheezing or whistling in the chest and regular use of inhalers |
Boulet et al. 2008 [35] April - August 2004, | Telephone survey | Assess influence of current and former smoking on self-reported asthma control and healthcare use | Adults aged 18–54 years with physician-diagnosed asthma for ≥6 months | Patient report of physician-diagnosed asthma |
Iron et al. 2003 [37] 1994/1995 | CNPHS data linked with OHIP | Determine the association between demographics, access to care, SES, and need (comorbidities) with actual family physician costs | Survey respondents aged ≥25 years consenting to share HC number and responses with MOHLTC | Self-reported |
Thanh et al. 2009 [48] 2005 | CCHS | To estimate the cost of asthma-related productivity loss days due to absenteeism and presenteeism* in Alberta | Survey respondents aged 18–64 years | Patient report of an asthma diagnosis |
Health economic analysis
| ||||
Seung et al. 2005 [42] 2004 | NACRS at CIHI, OCCI, MOHLTC billing | Determine the use of urgent care resources and the annual costs of the uncontrolled asthmatic population in Canada | NR | ICD-9 code 493 |
Key findings on economic burden
Patient-level direct costs
Reference/Study period | Age group | Patient group | Average total annual cost per patient | Inflated 2011 $CAD |
---|---|---|---|---|
Retrospective cohort studies
| ||||
Sadatsafavi et al. 2010 [10] Apr 1996 - Mar 2000 | 5-55 yrs | Narrow asthma definition | $331.15 | $366.17 |
Broad asthma definition | $443.93 | $490.88 | ||
To et al. 2008 [24] 1994 - 1998 | 0-9 yrs | 1994/1995 | $535.9 | $646.95 |
1995/1996 | $458.3 | $553.27 | ||
1996/1997 | $392.6 | $473.95 | ||
1997/1998 | $366.3 | $442.20 | ||
1998/1999 | $332.9 | $401.88 | ||
Ungar et al. 2001 [33] May - Oct 1995 | 0-14 yrs | Societal | $1,079 | $1,410.17 |
MOHLTC | $676 | $883.48 | ||
Patient | $76 | $99.33 |
Population-level direct costs
Reference/Study period | Age group | Patient group | Total annual population cost | Inflated 2011 $CAD |
---|---|---|---|---|
Retrospective cohort studies
| ||||
Sadatsafavi et al. 2010 [10] April 1996 - March 2000 | 5-55 yrs | Narrow asthma definition | $41,858,610 | $46,285,583 |
Broad asthma definition | $56,114,574 | $62,049,260 | ||
To et al. 2008 [24] 1994 - 1998 | 0-9 yrs | 1994/1995 | $116,700,000 | $140,882,165 |
1995/1996 | $114,800,000 | $138,588,454 | ||
1996/1997 | $106,900,000 | $129,051,443 | ||
1997/1998 | $105,300,000 | $127,119,897 | ||
1998/1999 | $98,900,000 | $119,393,711 |
Patient-level indirect costs
Population-level indirect costs
Humanistic burden studies
Overview
Reference/Study period | Design | Study objective | Inclusion criteria | Asthma definition |
---|---|---|---|---|
Miedinger et al. 2011 [51] 2004 - 2006 | Longitudinal study - subjects who claimed compensation for OA in Quebec | Examine association between clinical and socioeconomic variables and psychological and cost outcomes in patients with OA | Claimed compensation for OA at CSST, not exposed to offending allergens causing OA for ≥2 years | Workplace-associated respiratory symptoms and positive results in specific inhalation test |
Lavoie et al. 2010 [52] NR | Prospective cohort, self-report questionnaires | Assess level of psychological distress and range of disease-relevant emotional and behavioural coping styles in patients with severe vs. moderate asthma | Patients aged 18–69 years recruited from 2 tertiary care outpatient asthma clinics | Standard ATS criteria; Severe asthma - received adequate therapy and verified treatment adherence, with patients meeting ATS major and minor criteria for severe asthma |
Bacon et al. 2009 [53] Jun 2003 - Jan 2007 | Cross-sectional study; patients administered questionnaires | Assess associations between adult SES (measured according to educational level) and asthma morbidity, including asthma control; asthma-related emergency health service use; asthma self-efficacy, and asthma-related QoL | Patients aged 18–75 years, recruited from outpatient asthma clinic of Hôpital du Sacré-Coeur de Montréal | Physician-diagnosed asthma - charted 20% fall in FEV1 after methacholine challenge and/or bronchodilator reversibility in FEV1 of ≥20% predicted; severity based on GINA guidelines (mild intermittent, mild persistent, moderate persistent, and severe persistent) |
McTaggart-Cowan et al. 2008 [54] NR | Cross-sectional - self-administered questionnaire | Evaluate validity of HUI-3, EQ-5D, SF-6D, and AQL-5D to distinguish between different levels of asthma control | Patients aged 19–49 years,no other concurrent respiratory conditions | Self-reported, physician-diagnosed asthma |
Rowe et al. 2007 [55] NR | RCT (double-blind) -structured telephone interviews | Examine effect of adding a LABA (salmeterol) to fixed dose of oral prednisone and ICS (fluticasone) | Patients aged 18–55 years, PEF of <80% predicted before treatment, discharged from ED | Clinically diagnosed acute asthma in ED; PEF of <80% predicted before treatment |
Yacoub et al. 2007 [56] 2004 - 2006 | Retrospective cohort study; questionnaire administered to subjects | Evaluate utility of adding assessment of airway inflammation to standard assessment of impairment in subjects with OA; to evaluate psychological and QoL impact of OA | Workers' Compensation Agency of Quebec claimants | OA claimants |
Lavoie et al. 2006 [57] 2003 - 2005 | Cross-sectional study; structured psychiatric interview | Evaluate relative impact of having a depressive and/or anxiety disorder on asthma control and QoL | Patients aged 18–75 years with primary diagnosis of asthma | Physician-diagnosed asthma - chart evidence of 20% fall in FEV1 after methacholine challenge and/or bronchodilator reversibility in FEV1 20% predicted; severity classified according to international GINA guidelines |
Lavoie et al. 2006 [58] Jun 2003 to Apr 2004 | Cross-sectional study; patients completed ACQ and AQLQ questionnaires | Assess BMI in a Canadian sample of asthma outpatients, and evaluate associations between BMI and levels of asthma severity, asthma control, and asthma-related QoL | Patients aged 18–75 years with primary diagnosis of asthma, fluency in either English or French | Physician diagnosed asthma - chart evidence of 20% fall in FEV1 after methacholine challenge and/or bronchodilator reversibility in FEV1 20% predicted; severity classified according to GINA guidelines |
Lavoie et al. 2005 [52] NR | Cross-sectional study; patients completed ACQ and AQLQ questionnaires | Evaluate prevalence of psychiatric disorders in adult asthma patients and associations between psychiatric status, levels of asthma control, and asthma-related QoL | Patients aged 18–75 years with primary diagnosis of asthma, fluency in either English or French | Physician diagnosed asthma - confirmed by chart evidence of 20% fall in FEV1 after methacholine challenge and/or bronchodilator reversibility in FEV1 20% predicted; severity classified according to GINA guidelines |
Mo et al. 2004 [59] 2000 - 2001 | Cross-sectional study; HUI used to measure QoL | Measure HRQL of chronic disease and detect associations between HUI system and various chronic conditions | All household residents aged ≥12 years in all provinces and territories | NR |
FitzGerald et al. 2000 [60] | RCT - AQLQ administered to assess QoL | Compare effectiveness of prednisone and budesonide on relapse rate | Patients aged 15–70 years, recruited after discharge from ED after acute asthma exacerbation | Asthma exacerbation - progressive increase in dyspnea and history of asthma as per ATS criteria |
Williams et al. 2010 [61] Baseline to week 12 | RCT AQLQ data from first 12 weeks of the GOAL study | Compare AQLQ data across 16 countries (17 languages) | Patients aged 12 to <80 years with ≥6-month history of asthma | NR |
Miedinger et al. 2011 [51] 2004 to 2006 | Cross-sectional study; participants completed validated French versions of QoL questionnaires | Assess correlation between asthma-specific QoL and levels of psychological distress and psychiatric disorders in patients with OA | Patients who claimed compensation for OA at CSST; no longer exposed to sensitizing agents ≥2 years | OA - asthma caused and maintained by conditions attributable to the occupational environment and not to stimuli encountered outside the workplace |
Zimmerman et al. 2004 [50] 12-week study | RCT (double-blind); patients administered PAQLQ | Examine efficacy and safety of adding regular formoterol at 2 different doses to maintenance treatment with ICS in children with asthma not optimally treated by ICS alone | Patients aged 6–11 years with clinical diagnosis of asthma as per ATS criteria for ≥6 months; FEV1 50-90% of predicted normal; documented post-bronchodilator reversibility of ≥15%, ≥9% of predicted normal; treatment with regular ICS for ≥3 months before trial entry; asthma symptoms sufficient to suggest additional therapy may be needed; ability to use peak flow meter and Turbuhaler®, able to answer questions from PAQLQ; parent/guardian to complete daily diary | Clinical diagnosis of asthma defined according to ATS criteria; severe asthma exacerbation defined as asthma symptoms requiring oral corticosteroids or increase in dose of ICS as judged by the investigator |
Key findings on humanistic burden
Discussion
Limitations
Conclusions
Appendix
Medline (1996 to present) | ||
---|---|---|
1 | Asthma[MeSH] OR Asthma [Title,abstract] | 71642 |
2 | hospitalisation[MeSH] OR cost of illness[MeSH] OR absenteeism OR ambulatory care/Economics[MeSH] OR drug costs[MeSH] OR emergency medical services/Economics[EMTREE] OR healthcare costs[MeSH] OR nursing services/Economics[MeSH] OR physicians/Economics[MeSH] | 77559 |
3 | (burden OR clinical impact OR hospitalisation OR utilization OR burden of illness OR cost$1 OR cost of illness OR utilization OR nursing cost$1 OR physician cost$1 OR physician visit$1).TI,AB. | 354392 |
4 | 1 AND (2 OR 3) | 6208 |
5 | canada OR canadian OR alberta OR british columbia OR manitoba OR new brunswick OR newfoundland NEXT labrador OR northwest territories OR nova scotia OR nunavut OR ontario OR prince edward island OR quebec OR saskatchewan OR yukon NEXT territory | 462814 |
6 | 4 AND 5 AND LG=English AND HUMAN=YES | 430 |
7 | Publication Type=RANDOMIZED CONTROLLED TRIAL | 223783 |
8 | 6 NOT 7 | 398 |
9 | limit set 8 YEAR > 1999 | 324 |
EmBase (1992 to present) | ||
10 | Asthma[EMTREE] OR Asthma[Title,abstract] | 100645 |
11 | hospitalisation[EMTREE] OR cost of illness[EMTREE] OR cost[EMTREE] OR absenteeism[EMTREE] OR drug cost[EMTREE] OR healthcare cost[EMTREE] OR nursing cost[EMTREE] | 348772 |
12 | (burden OR clinical impact OR hospitalisation OR utilization OR burden of illness OR cost$1 OR cost of illness OR utilization OR nursing cost$1 OR physician cost$1 OR physician visit$1)[Title,abstract] | 381230 |
13 | 10 AND (11 OR 12) | 10735 |
14 | canada OR canadian OR alberta OR british columbia OR manitoba OR new brunswick OR newfoundland NEXT labrador OR northwest territories OR nova scotia OR nunavut OR ontario OR prince edward island OR quebec OR saskatchewan OR yukon NEXT territory | 462680 |
15 | 13 AND 14 AND LG=English AND HUMAN=YES | 654 |
16 | Randomized Controlled Trial[EMTREE] OR Randomized Controlled Trial Topic[EMTREE] | 249284 |
17 | 15 NOT 16 | 596 |
18 | limit set 17 YEAR > 1999 | 515 |
EMCare | ||
19 | Asthma[EMTREE] OR Asthma[Title,abstract] | 28554 |
20 | hospitalisation[EMTREE] OR cost of illness[EMTREE] OR cost[EMTREE] OR absenteeism[EMTREE] OR drug cost[EMTREE] OR healthcare cost[EMTREE] OR nursing cost[EMTREE] | 152470 |
21 | (burden OR clinical impact OR hospitalisation OR utilization OR burden of illness OR cost$1 OR cost of illness OR utilization OR nursing cost$1 OR physician cost$1 ORphysician visit$1)[Title,abstract] | 156234 |
22 | 19 AND (20 OR 21) | 4228 |
23 | canada OR canadian OR alberta OR british columbia OR manitoba OR new brunswick OR newfoundland NEXT labrador OR northwest territories OR nova scotia OR nunavut OR ontario OR prince edward island OR quebec OR saskatchewan OR yukon NEXT territory | 174145 |
24 | 22 AND 23 AND LG=EN | 312 |
25 | Randomized Controlled Trial[EMTREE] OR Randomized Controlled Trial[EMTREE] | 82273 |
26 | 24 NOT 25 | 278 |
27 | limit set 26 YEAR > 1999 | 222 |
Medline, EmBase and EMCare combined
| ||
28 | combined sets 9, 18, 27 | 1061 |
29 | dropped duplicates from 28 | 486 |
30 | unique records from 28 | 575 |
31 | split set 30 | 320 Medline |
32 | split set 30 | 234 EmBase |
33 | split set 30 | 21 EmCare |
Medline | ||
---|---|---|
1 | Asthma[MeSH] OR Asthma[Title,Abstract] | 71642 |
2 | Sickness impact profile[MeSH] OR quality of life[MeSH] OR patient satisfaction[MeSH] | 121478 |
3 | (quality of life OR QoL OR patient reported outcome$1 OR patient satisfaction OR emotional satisfaction OR patient dissatisfaction OR patient response OR gratification OR treatment satisfaction OR disability rate$1 OR health related quality of life OR HRQoL OR utilities) [Title,Abstract] | 119368 |
4 | 1 AND (2 OR 3) | 3035 |
5 | canada OR canadian OR alberta OR british columbia OR manitoba OR new brunswick OR newfoundland NEXTlabrador OR northwest territories OR nova scotia OR nunavut OR ontario OR prince edward island OR quebec OR saskatchewan OR yukon NEXT territory | 462814 |
6 | 4 AND 5 AND LG=English AND HUMAN=YES | 172 |
7 | limit set 6 YEAR > 1999 | 141 |
EmBase
| ||
8 | Asthma[EMTREE] OR Asthma[Title,Abstract] | 100645 |
9 | Sickness impact profile[EMTREE] OR quality of life[EMTREE] OR patient satisfaction[EMTREE] | 199618 |
10 | (quality of life OR QoL OR patient reported outcome$1 OR patient satisfaction OR emotional satisfaction OR patient dissatisfaction OR patient response OR gratification OR treatment satisfaction OR disability rate$1 OR health related quality of life OR HRQoL OR utilities) [Title,Abstract] | 124979 |
11 | 8 AND (9 OR 10) | 5651 |
12 | canada OR canadian OR alberta OR british columbia OR manitoba OR new brunswick OR newfoundland NEXT labrador OR northwest territories OR nova scotia OR nunavut OR Ontario OR prince edward island OR quebec OR saskatchewan OR yukon NEXT territory | 462680 |
13 | 11 AND 12 AND LG=English AND HUMAN=YES | 306 |
14 | limit set 13 YEAR > 1999 | 267 |
EMCare
| ||
15 | Asthma[EMTREE] OR Asthma[Title,Abstract] | 28554 |
16 | Sickness impact profile[EMTREE] OR quality of life[EMTREE] OR patient satisfaction[EMTREE] | 94595 |
17 | (quality of life OR QoL OR patient reported outcome$1 OR patient satisfaction OR emotional satisfaction OR patient dissatisfaction OR patient response OR gratification OR treatment satisfaction OR disability rate$1 OR health related quality of life OR HRQoL OR utilities) [Title,Abstract] | 48206 |
18 | 15 AND (16 OR 17) | 2178 |
19 | canada OR canadian OR alberta OR british columbia OR manitoba OR new brunswick OR newfoundland NEXT labrador OR northwest territories OR nova scotia OR nunavut OR Ontario OR prince edward island OR quebec OR saskatchewan OR yukon NEXT territory | 174145 |
20 | 18 AND 19 AND LG=English | 137 |
21 | limit set 20 YEAR > 1999 | 111 |
Medline, EmBase and EMCare combined
| ||
22 | combined sets 7, 14, 21 | 519 |
23 | dropped duplicates from 22 | 207 |
24 | unique records from 22 | 312 |
25 | split set 24 | 141 Medline |
26 | split set 24 | 158 EmBase |
27 | split set 24 | 13 EMCare |